Manipal Hospitals
| India | España | Turquía | |
| Radioterapia para el cáncer colorrectal | de $3,200 | de $10,000 | de $7,000 |
| Quimioterapia para el cáncer de mama | de $3,500 | de $3,500 | de $1,200 |
Bookimed no añade cargos extra a los precios de los tratamientos de Cáncer de hígado etapa 3. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Cáncer de hígado etapa 3 y cuentan con las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después de su tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de tratamiento de Cáncer de hígado etapa 3.
El Dr. Raj Nagarkar ha realizado más de 50,000 cirugías oncológicas con 30 años de experiencia de experiencia, especializándose en oncología quirúrgica de mama y tórax.
El Dr. Shaunak se especializa en terapias dirigidas para el cáncer de hígado, con investigaciones presentadas en la Sociedad Americana de Oncología Clínica (ASCO).
El Dr. Sridhar P.S. aporta una experiencia especializada en radioterapia para el cáncer de hígado, con credenciales de instituciones líderes.
La Dra. Shruti Kate se especializa en el tratamiento del cáncer de hígado avanzado, con experiencia en inmunoterapia y terapia metronómica del Tata Memorial Hospital.
La cirugía y los trasplantes de hígado para el cáncer de hígado en estadio 3 son posibles, pero muy selectivos. La elegibilidad depende del tamaño del tumor, la invasión vascular y la función hepática. Los centros indios utilizan terapias de reducción de estadio (downstaging) para reducir los tumores. Este proceso puede convertir a pacientes previamente no elegibles en candidatos para resección o trasplante.
Perspectiva del experto de Bookimed: India alberga algunos de los centros de trasplante de mayor volumen del mundo, como el Global Hospital Chennai, con más de 1.000 casos exitosos. Este volumen masivo permite a los cirujanos indios manejar casos complejos de estadio 3 que centros más pequeños podrían considerar inoperables. El Dr. Mohamed Rela, del Rela Institute, es un líder mundial en trasplantes de alta complejidad. Los pacientes deben buscar evaluaciones en estos centros especializados en trasplantes en lugar de clínicas de oncología general.
Consenso de los pacientes: Los pacientes señalan que los médicos a menudo priorizan la reducción del tumor mediante terapia sistémica antes de discutir la cirugía. Muchos enfatizan que una segunda opinión de un cirujano de trasplantes dedicado es vital para los casos de estadio 3.
India has top liver cancer specialists at JCI and NABH-accredited facilities. These facilities specialise in complex hepatobiliary oncology. Leading experts, such as Prof. Mohammed Rela and Dr Raj Nagarkar, manage advanced Stage 3 cases. They use robotic surgery, targeted therapies, and high-volume liver transplant programmes in Chennai, Delhi, and Gurgaon.
Bookimed Expert Insight: Data shows a clear distinction between multispecialty networks and dedicated cancer centres in India. Manipal Hospitals serves 2 million patients across 56 specialties. In contrast, centres like HCG Manavata focus solely on oncology with US-FDA audited research units. For Stage 3 cases, choosing these high-volume oncology hubs often provides access to TomoTherapy-H and Versa HD units. These units are not found in general hospitals.
Patient Consensus: Patients suggest consulting a hepatologist first. This consultation confirms the diagnosis before seeing an oncologist in India. They recommend prioritising curative options like resection or Y90 radiotherapy over palliative care. They also advise checking if VIP transfers and meals are included in private hospital packages.
In India, Stage 3 liver cancer treatment has roughly a 10% 4-year survival rate. Multidisciplinary protocols make this possible. Leading JCI-accredited hospitals use downstaging techniques like TACE and TARE to shrink tumours. This strategy turns advanced cases into candidates for curative surgery or organ transplants.
Bookimed Expert Insight: Indian liver centres like Apollo and Global Hospital function as high-volume hubs. They perform over 900 transplants annually. This massive case density allows Indian teams to accept complex Stage 3 cases. Such cases might be deemed inoperable elsewhere. Some facilities even offer combined liver-spinal or liver-kidney transplants for advanced patients.
Patient Consensus: Patients emphasise seeing a specialist liver surgeon first. They often find surgical options that general oncologists might overlook. Patients treated in India agree: confirm Y-90 or TACE treatment availability before travelling. This is vital for success.
Indian oncology centres offer curative pathways for stage 3 liver cancer through advanced downstaging protocols. While traditionally difficult to treat, specialists use TACE or radioembolisation (Y-90) to shrink tumours. This may help patients meet Milan criteria for life-saving liver transplants or surgical resections.
Bookimed Expert Insight: India excels in 'split liver' and minimally invasive transplants, which are critical for complex cases. Global Hospital Chennai has completed over 1,000 successful liver transplants. This high volume allows surgeons to accept complex stage 3 cases. These might be deemed inoperable elsewhere.
Patient Consensus: Remission is often possible if tumours shrink enough for surgery. Patients suggest getting a multidisciplinary team to review scans for downstaging eligibility in India.
Liver transplant eligibility for Stage 3 liver cancer in India requires meeting strict criteria. These include the Milan or UCSF benchmarks. Specialists at JCI-accredited centres like Apollo Hospital Indraprastha evaluate tumour size and number. They also check for vascular invasion. Treatment may include downstaging therapies to shrink tumours before surgery.
Bookimed Expert Insight: Indian clinics often accept advanced cases that Western hospitals might decline. Global Hospital Chennai reports a 95% five-year survival rate for liver transplants. Patients should check if clinics offer living donor transplants. This is vital as deceased donor waitlists in India often exceed one year.
Patient Consensus: Patients recommend getting three independent opinions from hepatologists to confirm the diagnosis. In India, people note the importance of finding a compatible living donor quickly. This prevents tumour progression.
Indian oncology centres manage Stage 3 liver cancer using locoregional therapies, targeted drugs, and immunotherapy. Specialists at JCI-accredited facilities like Apollo Hospital Indraprastha use TrueBeam STx and robotic systems to target tumours. Most protocols focus on downstaging tumours to enable potentially life-saving transplantation or resection.
Bookimed Expert Insight: Indian clinics offer a notable advantage in surgical volume for complex liver cases. At Global Hospital Chennai, surgeons maintain a 95% five-year survival rate for liver transplants. This high level of experience comes from over 1,000 successful transplants. It often makes them more willing to evaluate Stage 3 cases that other regions might deem inoperable.
Patient Consensus: Patients emphasise seeing a hepatobiliary surgeon rather than just a general oncologist. This helps check for curative surgery options. Many note that therapies like Y-90 or SBRT in India can effectively shrink tumours. This can make them eligible for a transplant.